ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 78 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $294,000 | +6.9% | 31,910 | -10.5% | 0.00% | 0.0% |
| Q4 2016 | $275,000 | -47.4% | 35,645 | -22.1% | 0.00% | -50.0% |
| Q3 2016 | $523,000 | -0.2% | 45,747 | +7.5% | 0.00% | -20.0% |
| Q2 2016 | $524,000 | +53.2% | 42,562 | +25.7% | 0.01% | +25.0% |
| Q1 2016 | $342,000 | -61.7% | 33,861 | -14.6% | 0.00% | -55.6% |
| Q4 2015 | $894,000 | -88.5% | 39,663 | -15.6% | 0.01% | +12.5% |
| Q3 2015 | $7,795,000 | +1063.4% | 46,986 | +57.8% | 0.01% | +33.3% |
| Q2 2015 | $670,000 | +75.4% | 29,780 | +100.9% | 0.01% | +100.0% |
| Q1 2015 | $382,000 | – | 14,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |